Your browser doesn't support javascript.
loading
Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2).
Lebwohl, Mark G; Leonardi, Craig L; Mehta, Nehal N; Gottlieb, Alice B; Mendelsohn, Alan M; Parno, Jeff; Rozzo, Stephen J; Menter, M Alan.
Afiliação
  • Lebwohl MG; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: lebwohl@aol.com.
  • Leonardi CL; Central Dermatology and Saint Louis University School of Medicine, St Louis, Missouri.
  • Mehta NN; National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Gottlieb AB; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Mendelsohn AM; Sun Pharmaceutical Industries, Inc, Princeton, New Jersey.
  • Parno J; Sun Pharmaceutical Industries, Inc, Princeton, New Jersey.
  • Rozzo SJ; Sun Pharmaceutical Industries, Inc, Princeton, New Jersey.
  • Menter MA; Division of Dermatology, Baylor Scott & White, Dallas, Texas; Texas A&M College of Medicine, Dallas, Texas.
J Am Acad Dermatol ; 84(2): 398-407, 2021 Feb.
Article em En | MEDLINE | ID: mdl-32961255
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Síndrome Metabólica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Síndrome Metabólica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article